Schedule

The ACCP Updates in Therapeutics®: Pharmacotherapy Preparatory Review and Recertification Course will be held Saturday and Sunday, April 27-28, 2019.

Click below for the full meeting schedule.

Updates in Therapeutics® 2019 Preparatory
Review and Recertification Courses
April 27-28, 2019


Pharmacotherapy Preparatory Review and Recertification Course -- General Psychiatry, Neurology, and Endocrine and Metabolic Disorders

Sunday, April 28, 2019 from 1:30 PM to 5:30 PM CDT at Academic and Research Building: First and Second Floors, Auditorium

Available for 3.75 hours of CPE credit
Activity Number: 0217-0000-19-076-L01-P

General Psychiatry
1:30 PM to 2:45 PM
Academic and Research Building: First and Second Floors, Auditorium

Speakers
Speaker: Jacintha S. Cauffield, Pharm.D., BCPS
Associate Professor of Pharmacy Practice, The Lloyd L. Gregory School of Pharmacy, Palm Beach Atlantic University, West Palm Beach, Florida
View Biography
Jacintha S. Cauffield, Pharm.D., BCPS
Cauffield

Learning Objectives
1. Examine pharmacotherapeutic options for managing major depression, bipolar disorder, schizophrenia, anxiety disorders, insomnia, and substance use disorder.
2. Select a drug used to treat these disorders on the basis of its unique pharmacologic properties, therapeutic efficacy, adverse effects, and cognitive and behavioral effects.
3. Formulate a pharmacotherapeutic treatment plan for a patient with a diagnosis of major depression, bipolar disorder, schizophrenia, anxiety disorder, insomnia, or substance use disorder.
Neurology
2:45 PM to 4:00 PM
Academic and Research Building: First and Second Floors, Auditorium

Speakers
Speaker: Timothy E. Welty, MA, Pharm.D., FCCP, BCPS
Professor of Pharmacy Practice and Chair of the Department of Clinical Sciences, Drake University, Des Moines, Iowa
View Biography
Timothy E. Welty, MA, Pharm.D., FCCP, BCPS
Welty

Learning Objectives
1. Identify the differences between convulsions, seizures, and status epilepticus.
2. Determine appropriate use of anti-seizure medications on the basis of their activity, adverse effects, and drug interactions for epilepsy and status epilepticus.
3. Identify appropriate treatment strategies for primary and secondary stroke prevention.
4. Determine the appropriateness of treatment with alteplase for acute stroke.
5. Initiate and monitor pharmacotherapy for Parkinson disease.
6. Differentiate between regimens for acute and prophylactic treatment of migraine, tension, and cluster headaches.
7. Identify appropriate therapies for individuals with multiple sclerosis.
8. Establish appropriate treatment for peripheral neuropathy.
Networking Break
4:05 PM to 4:15 PM
Academic and Research Building: Second Floor, Lobby
Browse the ACCP Bookstore, grab a beverage, and network with your fellow meeting attendees.
Endocrine and Metabolic Disorders
4:15 PM to 5:30 PM
Academic and Research Building: First and Second Floors, Auditorium

Speakers
Speaker: Brian K. Irons, Pharm.D., FCCP, BCACP
Professor of Pharmacy Practice, Texas Tech University Health Sciences Center, Lubbock, Texas
View Biography
Brian K. Irons, Pharm.D., FCCP, BCACP
Irons

Learning Objectives
1. Differentiate between the diagnostic and classification criteria for various endocrine and metabolic disorders, including type 1 and type 2 diabetes, diabetes insipidus, polycystic ovary syndrome, obesity, and disorders of the thyroid, adrenal, and pituitary glands.
2. Review the various therapeutic agents used in treating endocrine and metabolic disorders.
3. Select appropriate treatment and monitoring options for a given patient presenting with one of the previously mentioned endocrine or metabolic disorders.
4. Recommend appropriate therapeutic management for secondary complications from diabetes or thyroid disorders.